SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION ARTICLE M impact

Keros approves $5 million buyback after Takeda milestone

Keros announced a $5 million share repurchase program after receiving a $20 million development milestone from Takeda. It said cash supports operations into the second half of 2028.

KROS

Key Highlights:Original SEC Filing: Keros Therapeutics, Inc. [ KROS ] - 8-K - Sep. 08, 2026This is an AI-powered summary. It…